Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma: a reversible hyperplasia.

J J Brooks

    Lancet (London, England)
    |December 6, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Kaposi's sarcoma exhibits unusual traits, suggesting it may be a benign hyperplasia rather than a malignant neoplasm. This condition, strongly linked to immunodeficiency, shows potential for control and reversal.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endogenous CRF in rat large intestine mediates motor and secretory responses to stress.

    Neurogastroenterology and motility·2015
    Same author

    Alveolar soft part sarcoma metastatic to small bowel mucosa causing polyposis and intussuseption.

    Sarcoma·2008
    Same author

    Idiopathic hypereosinophilic syndrome with skull base involvement.

    AJNR. American journal of neuroradiology·2007
    Same author

    A patient's journey: living with breast cancer.

    BMJ (Clinical research ed.)·2006
    Same author

    Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade.

    Annals of surgical oncology·2001
    Same author

    A novel t(1;8)(p13;p11) in a thymic carcinoma with unusual giant cell features and renal metastasis.

    Cancer genetics and cytogenetics·2001
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    See all related articles

    Area of Science:

    • Oncology
    • Immunology
    • Pathology

    Background:

    • Kaposi's sarcoma presents with unique clinical and pathological characteristics.
    • These features challenge the traditional classification of the condition as a malignant neoplasm.

    Purpose of the Study:

    • To analyze the unusual features of Kaposi's sarcoma.
    • To re-evaluate its classification based on observed characteristics.

    Main Methods:

    • Review of clinical and pathological data of Kaposi's sarcoma cases.
    • Analysis of specific features including male preponderance, presentation pattern, spontaneous remission rates, predictable site involvement, lack of aneuploidy, and association with immunodeficiency.

    Main Results:

    • Kaposi's sarcoma demonstrates a significant male predominance.

    Related Experiment Videos

  • The condition appears in 'crops' and has a notable rate of spontaneous remission.
  • Predictable site involvement and lack of aneuploidy are characteristic, alongside a strong association with immunodeficiency.

    • Conclusions:

    • The collective evidence suggests Kaposi's sarcoma is not a malignant neoplasm.
    • It is proposed to be a benign, potentially controllable, and reversible hyperplasia.